The International Council for Harmonisation (ICH) is a unique project that brings together regulatory authorities and pharmaceutical industry representatives to
InSilicoTrials and Ikiminds recently engaged in a productive meeting with Dr. A Ramkishan, Deputy Drugs Controller of India (DCGI Hyderabad), to explore the immense potential of Artificial Intelligence and Modeling and Simulation in empowering pharmaceutical, life sciences, and medical device industries.
Connect with our in silico experts at InSilicoMinds today to discover how we can transform your journey in the world of innovation and efficiency.
Keywords:
The International Council for Harmonisation (ICH) is a unique project that brings together regulatory authorities and pharmaceutical industry representatives to discuss scientific and technical aspects of pharmaceutical product development and
We recently attended, A Deep Dive: FDA’s Model-Integrated Evidence (MIE) Industry Meeting Pilot Program for Generic Drugs Webinar and are excited to share the details with you.
As we strive for greater efficiency, cost-effectiveness, and patient access to innovative therapies, a groundbreaking concept has emerged – Model Master Files (MMFs).
FDA’s Center for Drug Evaluation and Research (CDER) is pleased to announce the new CDER Quantitative Medicine (QM) Center of Excellence (CoE).
Connect with our in silico team of experts to discuss AI solutions and advanced modeling and simulation for the Pharma and Life Science industries and hyper accelerate your success
Our Locations
Copyrights 2024 Ikiminds Pvt Ltd. All Rights Reserved
